News
-
-
-
PRESS RELEASE
BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
BioNxt Solutions Inc. provides update on proprietary sublingual thin-film drug delivery pipeline including Cladribine for multiple sclerosis, autoimmune disease expansion, Everolimus, and Semaglutide -
-
-
-
-
-
-
PRESS RELEASE
Taiwan Weeks 2026 set for Nov. 3-13 with expanded international participation
Taiwan Weeks 2026 to take place from Nov. 3-13, featuring global financial leaders and discussions on AI, ETFs, and market trends. Event aims to highlight Taiwan's role as a growing Asian Asset Management Center